Abstract
Abnormal blood pressure (BP) variability (BPV), occurring as beat-to-beat, 24 h, and day-to-day fluctuations, is related to target organ damage. However, the associations between abnormal BPV and renal structural changes have not been clearly investigated. We evaluated the day time and night time BP s.d. and average real variability (ARV), which reflected short-term BPV, the night time to day time (N/D) ratio of systolic BP (SBP), and the 7-day BPV, in 29 normotensive IgA nephropathy (IgAN) patients. We further compared the results with renal structural changes. The degree of arteriosclerosis was positively correlated with age, s.d. of night time SBP and the N/D ratio of SBP, and was negatively correlated with the estimated glomerular filtration rate (eGFR). The degree of arteriolar hyalinosis was positively correlated with age, night time SBP, s.d. of day time and night time SBP, day time and night time ARV, the N/D ratio of SBP and 7-day SBP, and was negatively correlated with the eGFR. A multiple linear regression analysis revealed that the level of arteriolar hyalinosis, but not arteriosclerosis, was associated with the s.d. of night time SBP (β=0.63, P<0.01) or night time ARV (β=0.61, P<0.01) after adjustment for age, sex, body mass index, the eGFR and night time SBP. Multiple linear regression analyses indicated no significant correlation between the degree of arteriolar hyalinosis and the N/D ratio of SBP or 7-day SBP s.d. or between the degree of arteriosclerosis and any of the BPV parameters. In conclusion, short-term night time BPV was found to be associated with arteriolar hyalinosis in normotensive IgAN patients.
Similar content being viewed by others
Introduction
Blood pressure (BP) fluctuates over a variety of durations, including beat-to-beat, 24 h and day-to-day, as well as over longer periods.1 Several studies have indicated that both short-term2, 3 and long-term4, 5 increases in BP variability (BPV) are associated with target organ damage, which includes increases in the left ventricular mass index and the carotid-intima media thickness, fatal and non-fatal cardiovascular events, and all-cause mortality. As the kidney is extremely vulnerable to BP, it is not surprising that abnormal BPV is associated with renal damage involving microalbuminuria or macroalbuminuria3 and a decreased glomerular filtration rate (GFR).6 However, the associations between abnormal BPV and renal structural changes have not been clearly investigated.
Invasive intra-arterial BP monitoring is required to accurately evaluate beat-to-beat BP fluctuations. However, this approach is not practical for measuring beat-to-beat BP fluctuation in many people. Therefore, the BP s.d. data7 or average real variability (ARV) index8, 9 that is collected by using 24 h ambulatory BP monitoring (ABPM) is used to estimate short-term BPV. An independent association between short-term BPV and a reduction in the GFR,10 and a correlation between short-term BPV and the left ventricular mass index11 have been demonstrated by using s.d. of systolic BP (SBP) data. The ARV index is a more precise parameter that reflects short-term BPV and is calculated with the following formula:8, 9
IgA nephropathy (IgAN) is the most common type of chronic and progressive glomerular disease.11 Hypertension-related and renal pathological changes, which include glomerular, vascular, tubular and interstitial lesions, are renal prognostic factors in IgAN patients.12 Wu et al.13 have reported that IgAN patients with intrarenal arteriosclerosis and arteriolar hyalinosis are more likely to have hypertension than patients without intrarenal arterial lesions. Although hypertension is the major risk factor for arteriosclerosis and arteriolar hyalinosis, ~50% of IgAN patients with normal office BP exhibit these pathological changes.13 Furthermore, ~30% and 25% of IgAN patients who are normotensive and have dipping circadian BP patterns have intrarenal arteriosclerosis and arteriolar hyalinosis changes, respectively.14
As BPV increases during the early stages of chronic kidney disease, even in normotensive subjects,3, 15 we hypothesized that increased BPV during the different time intervals might be another risk factor for renal arterial damage in normotensive IgAN patients. We evaluated the s.d. of SBP and day time and night time ARV; the night time to day time (N/D) ratio of SBP; and the s.d. of the BP values measured over 7 days in 29 normotensive IgAN patients and we compared the variability of these parameters with the renal structural changes.
Patients and methods
Patients
This study was approved by the Ethics Committee of the Hamamatsu University School of Medicine (No. 24-171) and was conducted in accordance with the principles of the Declaration of Helsinki. All subjects provided written informed consent for participation. We recruited 29 normotensive patients who were admitted to our hospital to undergo renal biopsies and were diagnosed with IgAN between February 2012 and May 2016. The inclusion criteria for this study were patients 20–65 years of age with an office BP<140/90 mm Hg without the use of antihypertensive agents. We excluded patients with concomitant diabetes mellitus, nephritic syndrome and severe kidney injury, which was defined as an estimated GFR (eGFR)<45 ml min−1 1.73 m−2, because these factors are known to be associated with arterial lesions.14
Study protocol
ABPM monitoring was conducted at 30 min intervals during the day and night with an automatic device (TM-2431; A and D, Tokyo, Japan). The day time and night time periods were defined according to the patients’ behavior records. Daytime, which was defined as the period from 0600 to 2100 h, and night time, which was defined as the period from 2100 to 0600 h, urine collections were conducted as previously described.16 Blood samples were drawn at 0600 h at the end of the ABPM. The mean BP values, s.d. and ARV were calculated for the day time and night time BP. The BP circadian rhythms were classified as extreme dipper, dipper, nondipper and riser when the N/D ratios of the SBP were <0.80, 0.80–<0.90, 0.90–1.0 and >1.0, respectively.
The SBP and the diastolic BP were measured every morning. We measured the BP for 8 days but excluded the data from the next day, which was when the renal biopsy was performed, and the mean BP and s.d. for the other 7 days were calculated.
Clinical data
The patients’ clinical data, including age, sex, body mass index and history of smoking, were collected at the time of admission. Serum creatinine (Cr), uric acid, total cholesterol and low-density lipoprotein cholesterol concentrations, as well as urinary Cr and protein concentrations, were measured in the clinical laboratory at the Hamamatsu University School of Medicine.
Histopathological data
The levels of arteriosclerosis (0: normal; 1: intimal thickness less than media thickness; and 2: intimal thickness more than media thickness) and arteriolar hyalinosis (the proportion of affected arterioles, 0: absent; 1: 1–25%; 2: 26–50%; and 3: 51–100%) in the intrarenal artery were scored in accordance with the Oxford classification of IgAN using sections stained by periodic acid-Schiff and Elastica van Gieson stains, respectively.17 The percentages of tubulointerstitial damage and global glomerulosclerosis were evaluated from sections stained with Masson’s trichrome and periodic acid-Schiff, respectively.
Statistical analyses
The results are expressed as mean± s.d. The significance of the differences between the patients with or without arteriosclerosis and arteriolar hyalinosis in relation to their clinical data was determined using Student’s t-test for unpaired samples. The correlations between the renal structural changes and the clinical parameters were evaluated using Pearson’s product–moment correlation test. Multiple linear regression analyses were conducted to evaluate the relationships between the renal structural changes, namely arteriosclerosis and arteriolar hyalinosis, and the different BPV parameters. Sex and body mass index were selected as variables, because these parameters are commonly used in multiple linear regression analyses. In addition, age, the eGFR and SBP were also adjusted, because they are associated with arterial lesions. We selected SBP parameters at the same time point as BPV parameters. We considered a value of P<0.05 to be statistically significant. The statistical analyses were performed using the IBMSPSS software, version 20 (IBM Corporation, Armonk, NY, USA).
Results
Patient characteristics
Renal biopsy was performed in a total of 201 patients at our hospital during the study duration. Sixty-nine of the patients were diagnosed as IgAN and 29 were enrolled in this study (Supplementary Figure 1). The baseline characteristics are presented in Table 1. The classification of the BP circadian rhythms showed that among the participants, 6 were dippers, 18 were nondippers and 5 were risers. None of the participants exhibited the extreme dipper BP pattern. Among the 29 patients, 4 took lipid-lowering agents and none received uric acid-lowering agents. Twenty-three patients consumed a low-salt diet containing 6 g per day of sodium chloride and the others consumed a standard diet (10 g per day of sodium chloride).
Relationships between the clinical data and the pathological changes
We investigated the correlations between the clinical parameters and the pathological changes. Intrarenal arteriosclerosis was positively correlated with age, the N/D ratio of s.d. of night time SBP, and it was negatively correlated with the eGFR. Arteriolar hyalinosis was positively correlated with age, the N/D ratio of SBP, the night time SBP, the s.d. of the day time and night time SBP, the day time and night time ARV and the 7-day SBP, and it was negatively correlated with the eGFR. The percentages of the glomerulosclerosis and the tubulointerstitial damage were positively correlated with age and the N/D ratio of SBP and were negatively correlated with the eGFR (Table 2). There were no significant correlations between renal pathological changes and the other risk factors, such as a history of smoking, the lipid profile and the serum uric acid concentration (Supplementary Table 1).
Clinical characteristics in the presence and absence of arteriosclerosis and arteriolar hyalinosis in the kidney
Given that the BPV parameters appeared to be related to arteriosclerosis and arteriolar hyalinosis lesions, we evaluated the clinical data in the presence and absence of these lesions. The IgAN patients with arteriosclerosis were significantly older, had lower eGFRs, had higher N/D ratios of SBP and tended to have higher night time BP, as compared with the IgAN patients who did not have arteriosclerosis. There were no significant differences between the IgAN patients who had and did not have arteriosclerosis in relation to day time BP, the s.d. of the day time and night time SBP, day time and night time ARV and the 7-day BP and s.d. (Table 3).
The IgAN patients with arteriolar hyalinosis had significantly higher N/D ratios of SBP, night time SBP, s.d. of the night time SBP and night time ARV, as well as lower eGFRs, as compared with patients who did not have arteriolar hyalinosis. The IgAN patients with arteriolar hyalinosis tended to be older and tended to have higher s.d. of the day time SBP and 7-day diastolic BP, as compared with patients who did not have arteriolar hyalinosis (Table 3).
Multiple linear regression analyses of the renal structural changes and the clinical parameters
We performed multiple linear regression analyses to evaluate the relationships between the renal structural changes, namely arteriosclerosis and arteriolar hyalinosis, and the clinical parameters. Multiple linear regression analyses showed that arteriolar hyalinosis was associated with the s.d. of night time SBP and night time ARV after adjustment for age, sex, body mass index, the eGFR and night time SBP. The multiple linear regression analyses also showed that the other BPV parameters, such as the s.d. of day time SBP, day time ARV, the N/D ratio of SBP and the s.d. of the 7-day BP, were not correlated with arteriolar hyalinosis after adjustment for age, sex, body mass index, the eGFR, day time SBP, night time SBP and the 7-day SBP (Table 4). A multiple linear regression analysis showed that the s.d. of day time and night time SBP, the day time and night time ARV, the N/D ratio of SBP and the s.d. of the 7-day SBP were not associated with arteriosclerosis (data not shown).
Discussion
Although the associations between target organ damage and the different types of BPV are well established,1 the associations between abnormal BPV and renal structural changes have not been clearly defined until now. In the present study, we recruited 29 normotensive IgAN patients and the results demonstrated that the degree of arteriolar hyalinosis, but not arteriosclerosis, was associated with the s.d. of night time SBP and night time ARV in the multiple linear regression analysis. Even though the mean BP in the IgAN patients was low, only 21% of the patients had normal BP circadian rhythms, and 62% and 17% of the patients had nondipper and riser patterns, respectively.
Haruhara et al.18 have investigated the correlation between ABPM parameters and renal histological changes in 138 patients with various types of kidney diseases and have demonstrated that day time and night time BP values are associated with tubulointerstitial damage but not arteriosclerosis or arteriolar hyalinosis. However, they did not investigate the short-term BPV. In addition, the N/D ratio of SBP was not found to be correlated with renal arterial lesions. However, 48% of the study patients received antihypertensive agents, which influenced not only BP but also the BPV. Furthermore, patients with diabetes mellitus, severe renal failure and various types of kidney disease were included, thus potentially influencing arterial lesions.19, 20 The discrepancy between their results and our results may be explained by the different patient characteristics.
The pathogenic mechanisms underlying arteriosclerosis and arteriolar hyalinosis are not fully understood.21 The results from a population-based autopsy study have shown that the prevalence of arteriosclerosis and arteriolar hyalinosis increase similarly with increasing age and BP.22 Wu et al.13 have reported that the prevalence of arterial lesions is 54.6% in IgAN patients, and 26.6% and 47.1% in non-IgAN and membranous nephropathy patients, respectively, even though the IgAN patients were younger when the renal biopsies were conducted. Furthermore, the prevalence of arteriolar hyalinosis is dramatically higher in IgAN patients (43.7%) compared with patients with other renal diseases, namely non-IgAN patients (16.8%) and membranous nephropathy patients (21.5%).13 Therefore, it is possible that the pathogenic mechanisms in IgAN patients may influence arteriolar hyalinosis. The reasons underlying the presence of an association between short-term BPV and arteriolar hyalinosis, but not between short-term BPV and atherosclerosis, remain unclear but may potentially explain the mechanisms aside from BP that affect arteriolar hyalinosis and arteriosclerosis.
We determined a correlation between abnormal BPV and arterial hyalinosis in normotensive IgAN patients. However, little is known about the associations between abnormal BPV and the renal pathological changes in hypertensive patients. Nagasawa et al.23 have demonstrated that urinary albumin excretion is associated with injury to the glomeruli and with pressure-associated injuries to the preglomerular vessels in spontaneously hypertensive stroke-prone rats. Furthermore, as the kidney has an autoregulatory vasoconstrictor response, an increase in the systemic BP does not directly affect intraglomerular pressure.24 It is possible that pressure-associated arteriolar injury has already occurred before glomerular basement membrane injury is detected as albuminuria or proteinuria. In fact, Zamami et al.25 have reported that dysregulated afferent arteriolar resistance via arteriolar sclerosis may affect hypertensive renal damage. The tonus of efferent arterioles is known to be regulated by several factors, such as the intrarenal renin-angiotensin system,26 decreased adenosine A2a receptor-mediated vasodilatation27 and increased asymmetrical dimethylarginine.28 However, the associations among ABPM, hyalinosis and failed autoregulation of efferent arterioles is not clear. Further studies are needed to clarify these relationships.
In this study, the multiple regression analysis showed that short-term night time, but not short-term day time, BPV was associated with arteriolar hyalinosis. Several studies have demonstrated that, compared with day time BP, nocturnal BP is superior at predicting the incidence of cardiovascular events and all-cause mortality.29, 30 Physical activity and environmental changes that influence short-term BPV are less frequent at night than during the day. As short-term night time BPV reflects endogenous factors rather than external factors, it is reasonable to assume that short-term night time BPV is more useful than short-term day time BPV for predicting renal structural changes.
Central sympathetic nervous system activation is a consequence of renal disease31, 32 and is an important mechanism underlying the augmentation of short-term BPV.1 In general, arterial lesions are increased by shear stress.33 However, other factors, including smoking, obesity, inflammation, reactive oxygen species and renin-angiotensin system, also influence arterial lesions.19, 20, 34 In particular, it is well known that both intrarenal renin-angiotensin system and reactive oxygen species are activated in IgAN patients and IgAN mouse models.35, 36 These morbidities may cause not only the progression of arterial hyalinosis but also incremental changes in short-term BPV via an activated central sympathetic nervous system. In the near future, we will design a study to clarify the relationships among arterial hyalinosis, short-term BPV and the central sympathetic nervous system.
A history of smoking, the lipid profile and the serum uric acid concentration are important risk factors for atherosclerosis. However, in the present study, there were only 2 and 4 patients who were current smokers and ex-smokers, respectively. Furthermore, the levels of average total cholesterol and uric acid were within normal limits (total cholesterol 193.8±37.1 mg dl−1 and uric acid 5.3±1.3 mg dl−1). These homogeneous and favorable patient characteristics may explain why these risk factors did not correlate with the arterial lesions.
There are some limitations to the present study. First, the study’s sample size was relatively small. Lin et al.14 have conducted logistic regression analyses of the abnormal BP circadian rhythms in 330 normotensive IgAN patients and have demonstrated that a nondipping BP pattern is associated with the eGFR, severe renal interstitial fibrosis, and arteriosclerosis in the renal arcuate arteries. Therefore, the present study’s inability to demonstrate an association between the N/D ratio of BP and renal structural damage in this study might be a consequence of the study being underpowered. However, an association between short-term night time BPV and arteriolar hyalinosis was demonstrated in normotensive IgAN patients in this study despite the small sample size. Second, the ABPM was performed and the BP was measured while the participants were hospitalized. An increase in day-to-day BPV is associated with the severity of the left ventricular mass index, increased carotid intima-media thickness and urinary albumin excretion.37 However, in this study we did not find any correlation between day-to-day BPV and renal pathological damage. Although little is known about the factors that influence day-to-day BPV, behavioral changes are considered the most likely influencing factors,38 thus potentially explaining the lack of an association between day-to-day BPV and structural renal arteriolar damage in this study.
In conclusion, short-term night time BPV was found to be associated with arteriolar hyalinosis in normotensive IgAN patients.
References
Parati G, Ochoa JE, Bilo G, Aqarwal R, Covic A, Dekker FW, Fliser D, Heline GH, Jaqer KJ, Garqani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossiqnol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA). Hypertension in chronic kidney disease part 2: role of ambulatory and home blood pressure monitoring for assessing alterations in blood pressure variability and blood pressure profiles. Hypertension 2016; 67: 1102–1110.
Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G . Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5: 93–98.
Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, Schillaci G, De Caterina R . Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007; 50: 325–332.
Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K . Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension 2011; 57: 1087–1093.
Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR . Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895–905.
Manios E, Tsagalis G, Tsivgoulis G, Barlas G, Koroboki E, Michas F, Alexaki E, Vemmos K, Zakopoulos N . Time rate of blood pressure variation is associated with impaired renal function in hypertensive patients. J Hypertens 2009; 27: 2244–2248.
Mancia G, Di Rienzo M, Parati G . Ambulatory blood pressure monitoring use in hypertension research and clinical practice. Hypertension 1993; 21: 510–524.
Mena L, Pintos S, Queipo NV, Aizpúrua JA, Maestre G, Sulbarán T . A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2005; 23: 505–511.
Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyurina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O’Brien E, Staessen JA . Prognostic value of reading-to-reading blood pressure variability over 24 h in 8938 subjects from 11 populations. Hypertension 2010; 55: 1049–1057.
Mulè G, Calcaterra I, Costanzo M, Geraci G, Guarino L, Foraci AC, Vario MG, Cerasola G, Cottone S . Relationship between short-term blood pressure variability and subclinical renal damage in essential hypertensive patients. J Clin Hypertens 2015; 17: 473–480.
Wyatt RJ, Julian BA . IgA nephropathy. N Eng J Med 2013; 368: 2402–2414.
Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L . Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol 2011; 22: 752–761.
Wu J, Chen X, Xie Y, Yamanaka N, Shi S, Wu D, Liu S, Cai G . Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant 2005; 20: 719–727.
Lin L, Zhang H, Yang J, Zhang J, Li K, Huo B, Dai H, Zhang W, Yang J, Tan W, He Y . Nocturnal and circadian rhythm of blood pressure is associated with renal structure damage and function in patients with IgAN. Arch Med Res 2016; 47: 25–32.
Soylu A, Yazici M, Duzenli MA, Tokac M, Ozdemir K, Gok H . Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives. Circ J 2009; 73: 899–904.
Isobe S, Ohashi N, Fujikura T, Tsuji T, Sakao Y, Yasuda H, Kato A, Miyajima H, Fujigaki Y . Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage. Clin Exp Nephrol 2015; 19: 231–239.
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Roberts IS Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Cool HT Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Troyanov S Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Alpers CE Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Amore A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Barratt J Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Berthoux F Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Bonsib S Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Bruijn JA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Cattran DC Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Coppo R Working Group of the International IgA Nephropathy Network and the Renal Pathology Society D’Agati V Working Group of the International IgA Nephropathy Network and the Renal Pathology Society D’Amico G Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Emancipator S Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Emma F Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Feehally J Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Ferrario F Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Fervenza FC Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Florquin S Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Fogo A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Geddes CC Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Groene HJ Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Haas M Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Herzenberg AM Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Hill PA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Hogg RJ Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Hsu SI Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Jennette JC Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Joh K Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Julian BA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Kawamura T Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Lai FM Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Li LS Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Li PK Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Liu ZH Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Mackinnon B Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Mezzano S Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Schena FP Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Tomino Y Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Walker PD Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Wang H Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Weening JJ Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Yoshikawa N Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Zhang H . The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009; 76: 546–556.
Haruhara K, Tsuboi N, Koike K, Fukui A, Miyazaki Y, Kawamura T, Ogura M, Yokoo T . Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients. Hypertens Res 2015; 38: 116–122.
Tracy RE, Ishii T . What is ‘nephrosclerosis’? lessons from the US, Japan, and Mexico. Nephrol Dial Transplant 2000; 15: 1357–1366.
Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Katafuchi R, Hirakata H, Okuda S, Tsuneyoshi M, Sueishi K, Fujishima M, Iida M . Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama study. Kidney Int 2003; 63: 1508–1515.
van Varik BJ, Rennenberg RJ, Reutelingsperger CP, Kroon AA, de Leeuw PW, Schurgers LJ . Mechanisms of arterial remodelling: lessons from genetic diseases. Front Genet 2012; 3: 290.
Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, Sueishi K, Tsuneyoshi M, Iida M, Kiyohara Y . Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama study. J Am Soc Nephrol 2007; 18: 2135–2142.
Nagasawa T, Mori T, Ohsaki Y, Yoneki Y, Guo Q, Sato E, Oba I, Ito S . Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats. Hypertens Res 2012; 35: 1024–1031.
Griffin KA, Picken MM, Bidani AK . Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 1995; 96: 793–800.
Zamami R, Kohagura K, Miyagi T, Kinjyo T, Shiota K, Ohya Y . Modification of the impact of hypertension on proteinuria by renal arteriolar hyalinosis in nonnephrotic chronic kidney disease. J Hypertens 2016; 34: 2274–2279.
Kobori H, Nangaku M, Navar LG, Nishiyama A . The intrarenal renin-angiotensin system: from physiology to the pathology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251–287.
Persson P, Hansell P, Palm F . Reduced adenosine A2a receptor-mediated efferent arteriolar vasodilation contributes to diabetes-induced glomerular hyperfiltration. Kidney Int 2015; 87: 109–115.
Okubo K, Hayashi K, Wakino S, Matsuda H, Kubota E, Honda M, Tokuyama H, Yamamoto T, Kajiya F, Saruta T . Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension. Hypertens Res 2005; 28: 181–189.
Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA . Predictive role of the night time blood pressure. Hypertension 2011; 57: 3–10.
Clement DL, De Buyzere ML, De Bacguer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O’Brien E . Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Eng J Med 2003; 348: 2407–2415.
Cao W, Li A, Wang L, Zhou Z, Su Z, Bin W, Wilcox CS, Hou FF . A salt-induced reno-cerebral reflex activations renin-angiotensin system and promotes CKD progression. J Am Soc Nephrol 2015; 26: 1619–1633.
Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Consentino F, Fouad-Tarazi F, Victor RG . Sympathetic overactivity in patients with chronic renal failure. N Eng J Med 1992; 327: 1912–1918.
Kaneko Y, Yoshita K, Kono E, Ito Y, Imai N, Yamamoto S, Goto S, Narita I . Extracapillary proliferation and arteriolar hyalinosis are associated with long-term kidney survival in IgA nephropathy. Clin Exp Nephrol 2016; 20: 569–577.
Salvatore SP, Troxell ML, Hecox D, Sperling KR, Seshan SV . Smoking-related glomerulopathy: expanding the morphologic spectrum. Am J Nephrol 2015; 41: 66–72.
Kobori H, Katsurada A, Ozawa Y, Miyata K, Hase N, Suzuki Y, Shoji T . Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun 2007; 358: 156–163.
Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, Kobori H . Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol 2009; 36: 750–755.
Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K . Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension 2011; 58: 1087–1093.
Murakami S, Otsuka K, Kubo Y, Shinagawa M, Matsuoka O, Yamanaka T, Nunoda S, Ohkawa S, Kitaura Y . Weekly variation of home and ambulatory blood pressure and relation between arterial stiffness and blood pressure measurements in community-dwelling hypertensives. Clin Exp Hypertens 2005; 27: 231–239.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Hypertension Research website
Supplementary information
Rights and permissions
About this article
Cite this article
Isobe, S., Ohashi, N., Ishigaki, S. et al. Increased nocturnal blood pressure variability is associated with renal arteriolar hyalinosis in normotensive patients with IgA nephropathy. Hypertens Res 40, 921–926 (2017). https://doi.org/10.1038/hr.2017.66
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/hr.2017.66
Keywords
This article is cited by
-
Blood Pressure Variability and the Progression of Chronic Kidney Disease: a Systematic Review and Meta-Analysis
Journal of General Internal Medicine (2023)
-
Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy
Journal of Nephrology (2022)
-
Normotensive non-dipping blood pressure profile does not predict the risk of chronic kidney disease progression
Hypertension Research (2019)
-
Impact of nocturnal blood pressure variability on renal arterioles
Hypertension Research (2018)
-
Night-time activation of the intrarenal renin–angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients
Hypertension Research (2018)